{'fraction_non_alphanumeric': 0.04088785046728972, 'fraction_numerical': 0.04030373831775701, 'mean_word_length': 4.989510489510489, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Efficacy and safety of Rosuvastatin versus Atorvastatin in patients with Hypercholestrolemia

A B S T R A C T The objective of the study was to measure efficacy and safety of Rosuvastatin-10mg versus Atorvastatin-20mg in patients with Hypercholesterolemia. We conducted a single centre retrospective study, involving 117 hypercholesterolemia patients between age group of 45-80 years. Data of both diabetic and nondiabetic patients with LDL-C: ≥140 - 60 mg/dl, Total Cholesterol: 200-240 mg/dl, Triglyceride: ≥165-≤400 mg/dl and VLDL: 40 mg and who were prescribed either Rosuvastatin 10mg or Atorvastatin 20mg were included in the study. A statistically significant reduction in LDL-C, TG, TC and VLDL was seen in both the groups. Similarly a statistically significant increase in HDL-C levels was observed in both the groups. Rosuvastatin showed a statistically significant reduction in TG at week 12 as compared to Atorvastatin. Decrease in LDL-C, TC, TG and VLDL was 22.3%, 16.3%, 30.1% and 31% respectively in Rosuvastatin group while the reduction was 15.5%, 13.7%, 19.2% and 23.4% respectively in Atorvastatin group. Rosuvastatin showed a greater improvement in lipid parameters as compared to Atorvastatin though this difference was not statistically significant. Both treatments were well tolerated with similar incidence of adverse events (Rosuvastatin 10 mg: 6.25% as compared to Atorvastatin 20 mg: 7.55%).Rosuvastatin was more effective than Atorvastatin in reducing LDL-C, Total Cholesterol, Triglyceride and VLDL. It was also better in increasing HDL-C as compared to Atorvastatin. Rosuvastatin therefore seems to be a better alternative from other statins in patients having Hypercholesterolemia.